Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Medullary thyroid cancer: molecular factors, management and treatment.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie - 1 Jan 2000

Pavlidis Efstathios, Sapalidis Konstantinos, Chatzinikolaou Fotios, Kesisoglou Isaak

Abstract excerpt

Medullary thyroid cancer (MTC) is an infrequent neuroendocrine tumor, which amounts to 3-5% of all thyroid malignancies. Approximately 75-80% of MTCs are sporadic neoplasms. The rest of 20-25% are familial cases that belong to multiple endocrine neoplasia (MEN) syndromes, specifically MEN2 and MEN3. These cases of familial MTC are attributed to an activating germline mutation of a tyrosine kinase receptor gene,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Neuroendocrine
Share to Multiple Endocrine Neoplasia Type 2a

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Neuroendocrine Tumor Research Advances

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins c-ret

Share to Thyroid Cancer Diagnosis and Treatment

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 33817709
DOI: 10.47162/RJME.61.3.06
PMCID: PMC8112777

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Medullary thyroid cancer: molecular factors, management and treatment.PMID 33817709Read ↗

Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment.Semantic proximity Read ↗

Medullary Thyroid Cancer: Molecular Biology and Novel Molecular TherapiesSemantic proximity Read ↗

Update on the Treatment of Medullary Thyroid Carcinoma in Patients with Multiple Endocrine Neoplasia Type 2.Semantic proximity Read ↗

Genetics of medullary thyroid cancer: An overview.Semantic proximity Read ↗

A review of diagnostic approaches to medullary thyroid carcinomaSemantic proximity Read ↗

Hereditary medullary thyroid carcinoma: the management dilemma.Semantic proximity Read ↗

Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectivesSemantic proximity Read ↗

Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes.Semantic proximity Read ↗

Management of medullary thyroid carcinoma.Semantic proximity Read ↗

MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectivesSemantic proximity Read ↗

Medullary thyroid carcinoma: recent advances and management update.Semantic proximity Read ↗

Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.